ATE347912T1 - IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENT FOR USE IN COMBINED X-ray and nuclear magnetic resonance imaging diagnostics - Google Patents
IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENT FOR USE IN COMBINED X-ray and nuclear magnetic resonance imaging diagnosticsInfo
- Publication number
- ATE347912T1 ATE347912T1 AT02758379T AT02758379T ATE347912T1 AT E347912 T1 ATE347912 T1 AT E347912T1 AT 02758379 T AT02758379 T AT 02758379T AT 02758379 T AT02758379 T AT 02758379T AT E347912 T1 ATE347912 T1 AT E347912T1
- Authority
- AT
- Austria
- Prior art keywords
- ionic
- ray
- combined
- magnetic resonance
- nuclear magnetic
- Prior art date
Links
- 239000002872 contrast media Substances 0.000 title abstract 2
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 title 1
- 238000005481 NMR spectroscopy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
- A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
- A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
The invention discloses the use of ionic and non-ionic radiographic contrast agents for combined X-ray and nuclear magnetic resonance (MRI) diagnostics.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI001706A ITMI20011706A1 (en) | 2001-08-03 | 2001-08-03 | IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENTS, USABLE FOR THE COMBINED DIAGNOSTIC INVESTIGATION THROUGH X-RAYS AND MAGNETIC RESONANCE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE347912T1 true ATE347912T1 (en) | 2007-01-15 |
Family
ID=11448229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02758379T ATE347912T1 (en) | 2001-08-03 | 2002-07-23 | IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENT FOR USE IN COMBINED X-ray and nuclear magnetic resonance imaging diagnostics |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8211404B2 (en) |
| EP (1) | EP1411992B1 (en) |
| JP (1) | JP4310187B2 (en) |
| AT (1) | ATE347912T1 (en) |
| DE (1) | DE60216770T2 (en) |
| DK (1) | DK1411992T3 (en) |
| ES (1) | ES2278946T3 (en) |
| IT (1) | ITMI20011706A1 (en) |
| WO (1) | WO2003013616A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE529135T1 (en) | 2004-03-11 | 2011-11-15 | Mallinckrodt Llc | X-RAY CONTRAST FORMULATION WITH A MIXTURE OF AN IODINATED MONOMER AND DIMER |
| DE102005028882A1 (en) * | 2005-06-22 | 2007-01-04 | Siemens Ag | A solution and method for assisting imaging on a patient |
| EP1907873B1 (en) * | 2005-07-21 | 2015-02-25 | Johns Hopkins University | Non-invasive mri measurement of tissue glycogen |
| EP2073723A4 (en) * | 2006-10-10 | 2011-03-30 | Mayo Foundation | REDUCTION OF TOXICITY INDUCED BY A CONTRAST AGENT |
| ES2413160T3 (en) * | 2007-10-12 | 2013-07-15 | Ge Healthcare As | Contrast agents |
| JP2011504939A (en) * | 2007-11-07 | 2011-02-17 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | Contrast agent |
| DE102007058220A1 (en) | 2007-12-03 | 2009-06-04 | Bayer Schering Pharma Aktiengesellschaft | New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors |
| JP2011506286A (en) * | 2007-12-05 | 2011-03-03 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | Contrast agent |
| US8535642B2 (en) * | 2008-02-27 | 2013-09-17 | Ge Healthcare As | Contrast agents |
| EP2243767A1 (en) * | 2009-04-21 | 2010-10-27 | Bracco Imaging S.p.A | Process for the iodination of aromatic compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2541272A1 (en) * | 1983-02-23 | 1984-08-24 | Guerbet Sa | BROMINE COMPOUNDS AND OPACIFIER PRODUCTS CONTAINING THEM |
| JPH10500999A (en) | 1995-02-24 | 1998-01-27 | ブラッコ リサーチ ソシエテ アノニム | Liposomal suspensions as blood pool imaging contrast agents |
| US5648536A (en) * | 1995-06-07 | 1997-07-15 | Dunn; Thomas Jeffrey | Process for producing ioversol |
| CN1221250C (en) * | 1998-04-09 | 2005-10-05 | 阿莫萨姆保健公司 | Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| EP1178837A2 (en) * | 1999-04-21 | 2002-02-13 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method for enhancing contrast produced by mri |
| FR2794744B1 (en) | 1999-06-09 | 2001-09-21 | Guerbet Sa | METAL COMPLEXES OF BICYCLIC POLYAMINOACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN MEDICAL IMAGING |
-
2001
- 2001-08-03 IT IT2001MI001706A patent/ITMI20011706A1/en unknown
-
2002
- 2002-07-23 WO PCT/EP2002/008183 patent/WO2003013616A1/en not_active Ceased
- 2002-07-23 JP JP2003518618A patent/JP4310187B2/en not_active Expired - Fee Related
- 2002-07-23 DE DE60216770T patent/DE60216770T2/en not_active Expired - Lifetime
- 2002-07-23 EP EP02758379A patent/EP1411992B1/en not_active Expired - Lifetime
- 2002-07-23 ES ES02758379T patent/ES2278946T3/en not_active Expired - Lifetime
- 2002-07-23 AT AT02758379T patent/ATE347912T1/en active
- 2002-07-23 US US10/485,878 patent/US8211404B2/en not_active Expired - Fee Related
- 2002-07-23 DK DK02758379T patent/DK1411992T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1411992A1 (en) | 2004-04-28 |
| ES2278946T3 (en) | 2007-08-16 |
| ITMI20011706A1 (en) | 2003-02-03 |
| EP1411992B1 (en) | 2006-12-13 |
| JP2005505527A (en) | 2005-02-24 |
| US8211404B2 (en) | 2012-07-03 |
| WO2003013616A8 (en) | 2004-04-08 |
| ITMI20011706A0 (en) | 2001-08-03 |
| US20050113675A1 (en) | 2005-05-26 |
| DK1411992T3 (en) | 2007-04-10 |
| WO2003013616A1 (en) | 2003-02-20 |
| DE60216770T2 (en) | 2007-04-12 |
| DE60216770D1 (en) | 2007-01-25 |
| JP4310187B2 (en) | 2009-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991688D0 (en) | Manageable compositions and methods for magnetic resonance imaging | |
| Gorelik et al. | Early detection of metastases using whole-body MRI for initial staging and routine follow-up of myxoid liposarcoma | |
| DK0907379T3 (en) | Bioactivated diagnostic imaging contrast agent | |
| ATE347912T1 (en) | IONIC AND NON-IONIC RADIOGRAPHIC CONTRAST AGENT FOR USE IN COMBINED X-ray and nuclear magnetic resonance imaging diagnostics | |
| DE60035240D1 (en) | Marker for computed tomography and MRI imaging | |
| DE69941912D1 (en) | Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents | |
| IS2127B (en) | Metallic constituents containing perfluoroalkyl and their use in magnetic resonance imaging | |
| PL309395A1 (en) | Injectable aqueous preparations useful in x-ray diagnostics, containing iodised aromatic compounds used as x-raying contrast media | |
| ITSV980052A0 (en) | PATIENT BED OR SIMILAR, AND MACHINE, IN PARTICULAR FOR THE DETECTION OF NUCLEAR MAGNETIC RESONANCE IMAGING IN COMBINATION | |
| PL323919A1 (en) | Free heterocyclic methyl radicals as agent improving imaging | |
| ATE195432T1 (en) | IODINATED PARAMAGNETIC CHELATES AND THEIR USE AS CONTRAST AGENTS | |
| ATE519505T1 (en) | REACTIVE PARAMAGNETIC CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | |
| ATE345355T1 (en) | PEPTIDE CONJUGATES, THEIR DERIVATIVES WITH METAL COMPLEXES AND THEIR USE FOR MAGNETIC RESONANCE IMAGING | |
| NO940115D0 (en) | Contrast agents for X-ray and magnetic tomographic imaging | |
| Glans et al. | Maintaining image quality while reducing acoustic noise and switched gradient field exposure during lumbar MRI | |
| ES2117670T3 (en) | DERIVED FROM HYDROXAMATE AND HYDRAZIDE OF POLYAMINS AND THEIR MEDICAL USE AS CHELATING AGENTS. | |
| ATE365170T1 (en) | COMPLEX COMPOUNDS OF PARAMAGNETIC METAL AND PHTHALOCYANINE AND CONTRAST AGENT USING THESE COMPOUNDS | |
| BR9508435A (en) | Macrocyclic chelates and their chelates and their uses in the diagnostic field | |
| DK0759785T3 (en) | Liposome suspensions as blood contrast agents | |
| EP1749026A4 (en) | LABELED ADRENOMEDULLIN DERIVATIVES AND THEIR USE TO IMAGE AND THERAPY | |
| AU2002325358A1 (en) | Ionic and non-ionic radiographic contrast agents for use in combined x-ray and nuclear magnetic resonance diagnostics | |
| Rathebe | Occupational exposure to static magnetic fields from MRI units in health care settings: a narrative review | |
| DE602004022301D1 (en) | GLYCEROPHOSPHOCHOLIN AND DERIVATIVES THEREOF FOR THE MEDICAL FIGURE OF NEUROPSYCHIATRIC ILLNESSES | |
| Hansson | Safety and health effects in high and ultra-high field MR | |
| JPH0360642A (en) | Fixed position-brain operation device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1411992 Country of ref document: EP |